CLASEPRUBART
UNII LDW8BPL8GB

Substance Identification & Data

This profile provides standardized clinical and technical data for Claseprubart, uniquely identified by the FDA Unique Ingredient Identifier (UNII) LDW8BPL8GB.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2922766-89-8 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

LDW8BPL8GB

CAS Registry Number

2922766-89-8

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

CLASEPRUBART

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C216014

National Cancer Institute reference terminology for clinical and research data.

INN ID

13138

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Claseprubart. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

CLASEPRUBART

CLASEPRUBART [INN]

IMMUNOGLOBULIN G4 (40-ALANINE,77-ASPARAGINE,100-GLUTAMIC ACID,101-ASPARAGINE,225-PROLINE,232-GLUTAMIC ACID,249-TYROSINE,251-THREONINE,253-GLUTAMIC ACID,DE-C-TERMINAL LYSINE), ANTI-(HUMAN/MACACA FASCICULARIS COMPLEMENT C1S) (HUMAN MONOCLONAL DNTH103 .GAMMA.4-CHAIN), DISULFIDE WITH RECOMBINANT HUMAN MONOCLONAL DNTH103 .KAPPA.-CHAIN, DIMER

IMMUNOGLOBULIN G4-KAPPA, ANTI-(HOMO SAPIENS C1S (COMPLEMENT C1S)), HOMO SAPIENS MONOCLONAL ANTIBODY (H-GAMMA4 HEAVY CHAIN HOMO SAPIENS (1-443) (VH (HOMO SAPIENS IGHV3-11*01 (96.9%) -(IGHD) -IGHJ1*01 (100%), CDR-IMGT (8.8.10) (26-33.51-58.97-106)) (1-117) -HOMO SAPIENS IGHG4*01, NG4M(A) CH2 L92, 12-G4V5 H P10, 6-G4V3 CH2 E1.2, 9-G4V21 CH2 Y15.1, T16, E18 (CH1 (118-215), HINGE 1-12 S10>P (225) (216-227), CH2 L1.2>E (232), M15.1>Y (249), S16>T (251), T18>E (253), L92 (306) (228-337), CH3 (338-442), CHS K2>DEL (443)) (118-443)), (131-214')-DISULFIDE WITH L-KAPPA LIGHT CHAIN HOMO SAPIENS (1'-214') (V-KAPPA (HOMO SAPIENS IGKV1-33*01 (95.8%) -IGKJ4*01 (100%), CDR-IMGT (6.3.9) (27'-32'.50'-52'.89'-97')) (1'-107') -HOMO SAPIENS IGKC*01 (100%) KM3 A45.1, V101 (C-KAPPA A45.1 (153'), V101 (191')) (108'-214')); DIMER (223-223'':226-226'')-BISDISULFIDE, PRODUCED IN CHINESE HAMSTER OVARY (CHO) CELLS, CELL LINE CHO-K1, GLYCOFORM ALFA)

External Clinical & Regulatory Resources

Previous UNIILDV98UN52Y

Next UNIILDW8N7SC44